PROGENICS PHARMACEUTICALS INC 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Jun 15, 2015
Insider Transaction Report
Form 4
ISRAEL ROBERT J
Sr. VP, Medical Affairs
Transactions
- Exercise/Conversion
Common Stock
2015-06-11$5.33/sh+2,000$10,660→ 37,050 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2015-06-11$6.83/sh−2,000$13,660→ 4,000 totalExercise: $5.33From: 2010-07-01Exp: 2019-07-01→ Common Stock (2,000 underlying) - Sale
Common Stock
2015-06-11$6.83/sh−2,000$13,660→ 35,050 total
Footnotes (1)
- [F1]The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer.